Fact
Sheet:
Infiniti™
Vision System
The Infiniti™ Vision System is
a revolutionary new lens-removal system from Alcon, the global leader in
ophthalmic surgical devices.
Benefits
- Removes a lenses clouded by cataracts
to help improve patients’ quality of life through clarity of vision.
- New technology may reduce the risk of
thermal burns and other potential complications associated with other
methods of removal.
·
Increased flexibility and greater options provide surgeons
with more control over the lens-removal procedure, which potentially offers the
reduced risk of complications.
Features
- The Infiniti™ Vision System’s tri-modal
energy delivery options offer surgeons greater choice in picking the
surgical method best suited to their patient’s needs.
- The AquaLase®*
Liquefaction Device is a completely
new lens removal method that uses pulsed surgical solution to safely break
up and remove the natural lens material.
This method represents the first departure from the industry
standard for almost 20 years, and is only available with the Alcon Infiniti™ Vision System. It breaks up the clouded lens with
pulses of warm, naturally balanced solution to “wash away” the lens. The new technology may reduce the risk
of thermal burns and other potential complications.
- Industry
standard, advanced ultrasound phacoemulsification,
also is an option with the Infiniti™
Vision System. With this method, a
metal probe vibrating at ultrasound frequency is used to soften and break
up the lens. The Infiniti™ Vision System features an
improved ultrasound handpiece that makes it easier for surgeons to hold
and control.
- A third
method uses both ultrasound and oscillation to help break up the cataract faster, and may allow the
surgeon greater control of lens tissue than traditional ultrasound.
Availability
- Debuted at the American
Society of Cataract and Refractive Surgery (ASCRS) Symposium, April 2003,
in San Francisco.
- Became available to U.S.
ophthalmologists in late-summer 2003.
AquaLase® is
based on technology invented by Mark S. Andrew, MD and Mylina
Lincoln-Andrew, MS